首页> 外文期刊>Diabetes research and clinical practice >A potential novel pathological implication of serum soluble triggering receptor expressed on myeloid cell 2 in insulin resistance in a general Japanese population: The Hisayama study
【24h】

A potential novel pathological implication of serum soluble triggering receptor expressed on myeloid cell 2 in insulin resistance in a general Japanese population: The Hisayama study

机译:血清可溶性触发受体对骨髓细胞2在胰岛素抵抗中表达的血清可溶性触发受体的潜在新病理意义:Hisayama研究

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: No cohort study has examined the pathological significance of triggering receptor expressed on myeloid cell 2 (TREM2), a cell surface receptor expressed on myeloid lineage cells, and its soluble form, sTREM2, in insulin resistance in a general population.
机译:目的:没有队列研究检测了在骨髓谱系细胞中表达的粘骨细胞2(Thread2)的触发受体的病理意义,其在一般人群中胰岛素抵抗力的细胞表面受体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号